BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2912232)

  • 21. Selective and nonselective monoamine oxidase inhibitors: behavioral disturbances during their administration to depressed patients.
    Pickar D; Murphy DL; Cohen RM; Campbell IC; Lipper S
    Arch Gen Psychiatry; 1982 May; 39(5):535-40. PubMed ID: 7092487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MAOI-induced rapid cycling bipolar affective disorder in an adolescent.
    Mattsson A; Seltzer RL
    Am J Psychiatry; 1981 May; 138(5):677-9. PubMed ID: 6786112
    [No Abstract]   [Full Text] [Related]  

  • 24. Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.
    Robinson DS; Lerfald SC; Bennett B; Laux D; Devereaux E; Kayser A; Corcella J; Albright D
    Psychopharmacol Bull; 1991; 27(1):31-9. PubMed ID: 1862204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyramine sulfate excretion may be a better predictor of antidepressant response than monoamine oxidase activity.
    Stewart JW; Harrison W; Cooper TB; Quitkin FM
    Psychiatry Res; 1988 Aug; 25(2):195-201. PubMed ID: 3051071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet monoamine oxidase activity and clomipramine-induced mania in unipolar depressed patients.
    van Kammen DP; van Scheyen JD; Murphy DL
    Biol Psychiatry; 1980 Aug; 15(4):565-73. PubMed ID: 7397287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interrelationship of hysteroid dysphoria and borderline personality disorder.
    Liebowitz MR; Klein DF
    Psychiatr Clin North Am; 1981 Apr; 4(1):67-87. PubMed ID: 7232238
    [No Abstract]   [Full Text] [Related]  

  • 28. Phenelzine in depressed patients. Effects on urinary MHPG excretion in relation to clinical response.
    Beckmann H; Murphy DL
    Neuropsychobiology; 1977; 3(1):49-55. PubMed ID: 895998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monoamine oxidase inhibitor-induced speech blockage.
    Goldstein DM; Goldberg RL
    J Clin Psychiatry; 1986 Dec; 47(12):604. PubMed ID: 3782047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment dexamethasone suppression test as a predictor of response to phenelzine.
    Janicak PG; Pandey GN; Sharma R; Boshes R; Bresnahan D; Davis JM
    J Clin Psychiatry; 1987 Dec; 48(12):480-2. PubMed ID: 3693333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A; McCue RE; Friedman E; Cooper TB
    J Clin Psychopharmacol; 1987 Dec; 7(6):413-6. PubMed ID: 3323263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet monoamine oxidase in depressed subjects treated with phenelzine.
    Davidson J; McLeod MN; White HL
    Am J Psychiatry; 1978 Apr; 135(4):470-2. PubMed ID: 345826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implications of monoamine oxidase inhibitor-induced hypomania.
    Cohen R; Pickar D
    Arch Gen Psychiatry; 1978 Nov; 35(11):1393-4. PubMed ID: 708198
    [No Abstract]   [Full Text] [Related]  

  • 34. Acetylator status and inhibition of platelet monoamine oxidase following treatment with phenelzine.
    Yates CM; Loudon JB
    Psychol Med; 1979 Nov; 9(4):777-9. PubMed ID: 515276
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug-induced catatonia.
    Herrmann N; Lieff SJ
    Can J Psychiatry; 1988 Oct; 33(7):633-4. PubMed ID: 3197020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phenelzine v imipramine in atypical depression. A preliminary report.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin J; Tricamo E; Markowitz JS; Klein DF
    Arch Gen Psychiatry; 1984 Jul; 41(7):669-77. PubMed ID: 6375621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma levels of catecholamines and dihydroxyphenylglycol during antidepressant drug treatment.
    Robinson DS; Johnson GA; Nies A; Corcella J; Cooper TB; Albright D; Howard D
    J Clin Psychopharmacol; 1983 Oct; 3(5):282-7. PubMed ID: 6355207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tap (draft) beer and monoamine oxidase inhibitor dietary restrictions.
    Shulman KI; Tailor SA; Walker SE; Gardner DM
    Can J Psychiatry; 1997 Apr; 42(3):310-2. PubMed ID: 9114949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated platelet monoamine oxidase activity in patients wth nonendogenous depression.
    White K; Shih J; Fong T; Young H; Gelfand R; Boyd J; Simpson G; Sloane RB
    Am J Psychiatry; 1980 Oct; 137(10):1258-9. PubMed ID: 7416279
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.